[Retinal protection during eye surgery]
Benguria-Arrate G, Guitérrez-Ibarluzea I, Galnares-Cordero L
Record ID 32018000539
Spanish
Original Title:
Protector de la retina durante la cirugía ocular
Authors' objectives:
To assess the effectiveness and possible benefits and adverse effects of PLGA [poly(lactic-co-glycolic acid)] microparticles.
Authors' results and conclusions:
No studies in humans that provide information concerning the use of microparticles with this indication have been found.
Conclusions
The results of current studies regarding the use of PLGA microparticles in humans are required.
Authors' methods:
A time-unrestricted search of the scientific literature in databases that collect primary, secondary and applied research studies, namely the Medline, CRD (INAHTA, NHS EED, DARE), Cochrane Collaboration, National Guidelines ClearingHouse (NGC), EuroScan and ECRI databases, in order to locate systematic reviews, clinical practice guidelines or clinical trials that analyse the technique under study.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www.euskadi.eus/contenidos/informacion/2014_osteba_publicacion/es_def/adjuntos/protec_retina.pdf
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
Spain
MeSH Terms
- Vitrectomy
- Retina
- Vitreoretinal Surgery
- Polylactic Acid-Polyglycolic Acid Copolymer
- Ophthalmologic Surgical Procedures
Keywords
- Vitrectomy
- Retina
- Vitreoretinal Surgery
- Polylactic Acid-Polyglycolic Acid Copolymer
- Copolímero de Ácido Poliláctico-Ácido Poliglicólico
- Cirugía Vitreorretiniana
- Vitrectomía
Contact
Organisation Name:
Basque Office for Health Technology Assessment
Contact Address:
C/ Donostia – San Sebastián, 1 (Edificio Lakua II, 4ª planta) 01010 Vitoria - Gasteiz
Contact Name:
Lorea Galnares-Cordero
Contact Email:
lgalnares@bioef.eus
Copyright:
Osteba (Basque Office for Health Technology Assessment) Health Department of the Basque Government
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.